A new model for predicting acute mucosal toxicity in head-and-neck cancer patients undergoing radiotherapy with altered schedules

International Journal of Radiation Oncology Biology Physics

Volumn 83, Issue 5, 2012, Pages

  Strigari, Lidia ^a   Pedicini, Piernicola ^b   D'Andrea, Marco ^a   Pinnarò, Paola ^a   Marucci, Laura ^a   Giordano, Carolina ^a   Benassi, Marcello ^c  

^a REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^b REFERRAL CANCER CENTER OF BASILICATA   (Italy)

^c DEPARTMENT OF MEDICAL ONCOLOGY   (Italy)

Author keywords

Altered schedules; Head and neck cancer; Intolerable treatments; Mucositis; Radiotherapy

Indexed keywords

ALTERED SCHEDULES; AREA UNDER THE CURVES; CANCER PATIENTS; CONFIDENCE INTERVAL; EQUIVALENT DOSE; GOLD STANDARDS; HEAD-AND-NECK CANCER; INTOLERABLE TREATMENTS; MUCOSITIS; NORMAL-TISSUE COMPLICATION PROBABILITY MODELS; OVERALL TREATMENT TIME; PEARSON CORRELATION; PREDICTIVE MODELS; RADIATION-INDUCED;

CORRELATION METHODS; DISEASES; FORECASTING; RADIATION EFFECTS; TISSUE; TOXICITY;

RADIOTHERAPY;

ACUTE MUCOSAL TOXICITY; AREA UNDER THE CURVE; ARTICLE; CANCER PATIENT; CANCER RADIOTHERAPY; DISEASE SEVERITY; HEAD AND NECK CANCER; MOUTH MUCOSA; MUCOSA INFLAMMATION; NORMAL TISSUE COMPLICATION PROBABILITY MODEL; PRIORITY JOURNAL; RADIATION DOSE; RADIATION INJURY; STATISTICAL MODEL;

ACUTE DISEASE; AREA UNDER CURVE; DOSE FRACTIONATION; HEAD AND NECK NEOPLASMS; HUMANS; MODELS, BIOLOGICAL; MOUTH MUCOSA; MUCOSITIS; ORGANS AT RISK; PHARYNX; RADIATION INJURIES; RADIATION TOLERANCE;

EID: 84863630720     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2012.02.004     Document Type: Article

References (19)

1. J.F. Fowler, and M.J. Lindstrom Loss of local control with prolongation in radiotherapy Int J Radiat Oncol Biol Phys 23 1992 457 467
2. J.H. Kaanders, A.J. van der Kogel, and K.K. Ang Altered fractionation: limited by mucosal reactions? Radiother Oncol 50 1999 247 260
3. H.R. Withers Biologic basis for altered fractionation schemes Cancer 55 9 Suppl 1985 2086 2095
4. H.R. Withers, J.M. Taylor, and B. Maciejewski The hazard of accelerated tumor clonogen repopulation during radiotherapy Acta Oncol 27 1988 131 146
5. S.M. Bentzen, M.I. Saunders, and S. Dische Radiotherapy-related early morbidity in head and neck cancer: quantitative clinical radiobiology as deduced from the CHART trial Radiother Oncol 60 2001 123 135
6. J.F. Fowler 21 years of biologically effective dose Br J Radiol 83 2010 554 568
7. J.F. Fowler Biological factors influencing optimum fractionation in radiation therapy Acta Oncol 40 2001 712 717
8. J.F. Fowler Is there an optimum overall time for head and neck radiotherapy? A review, with new modelling Clin Oncol (R Coll Radiol) 19 2007 8 22
9. J.F. Fowler The radiobiology of prostate cancer including new aspects of fractionated radiotherapy Acta Oncol 44 2005 265 276
10. J.F. Fowler, P.M. Harari, and F. Leborgne Acute radiation reactions in oral and pharyngeal mucosa: tolerable levels in altered fractionation schedules Radiother Oncol 69 2003 161 168
11. J.D. Fenwick, G.P. Lawrence, and Z. Malik Early mucosal reactions during and after head-and-neck radiotherapy: dependence of treatment tolerance on radiation dose and schedule duration Int J Radiat Oncol Biol Phys 71 2008 625 634
12. L. Strigari, G. Arcangeli, and S. Arcangeli Mathematical model for evaluating incidence of acute rectal toxicity during conventional or hypofractionated radiotherapy courses for prostate cancer Int J Radiat Oncol Biol Phys 73 2009 1454 1460
13. A. Hartley, P. Sanghera, and W. Kazi Correlation of currently used radiobiological parameters with local control and acute and late mucosal toxicity in randomised studies of altered fractionation for locally advanced head and neck cancer Clin Oncol (R Coll Radiol) 23 2011 29 33
14. L. Begnozzi, F.P. Gentile, and A.M. Di Nallo A simple method to calculate the influence of dose inhomogeneity and fractionation in normal tissue complication probability evaluation Strahlenther Onkol 170 1994 590 594
15. J.D. Cox, J. Stetz, and T.F. Pajak Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC) Int J Radiat Oncol Biol Phys 31 1995 1341 1346
16. L.E. Dodd, and M.S. Pepe Partial AUC estimation and regression Biometrics 59 2003 614 623
17. H.R. Withers, and H.D. Thames Dose fractionation and volume effects in normal tissues and tumors Am J Clin Oncol 11 1988 313 329
18. B. Maciejewski, H.R. Withers, and J.M. Taylor Dose fractionation and regeneration in radiotherapy for cancer of the oral cavity and oropharynx. Part 2. Normal tissue responses: acute and late effects Int J Radiat Oncol Biol Phys 18 1990 101 111
19. G.A. Plataniotis, and R.G. Dale Use of concept of chemotherapy-equivalent biologically effective dose to provide quantitative evaluation of contribution of chemotherapy to local tumor control in chemoradiotherapy cervical cancer trials Int J Radiat Oncol Biol Phys 72 2008 1538 1543